Showing results (41-50 of 569) with videos related to

Sort By:
Pageof 57
American Journal of Human Genetics|August 4, 2004
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2David E Goldgar, Douglas F Easton, Amie M Deffenbaugh, et al.
Plos One|December 21, 2013
SoftSearch: integration of multiple sequence features to identify breakpoints of structural variationsSteven N Hart, Vivekananda Sarangi, Raymond Moore, et al.
Comparative Medicine|July 1, 2008
Spontaneous vulvar papillomas in a colony of mice used for pancreatic cancer researchNaomi M Gades, Akihiro Ohash, Lisa D Mills, et al.
Annals of Surgical Oncology|June 25, 2016
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast CancerAkiko Chiba, Tanya L Hoskin, Emily J Hallberg, et al.
Cancer Research|February 8, 2005
Functional evaluation and cancer risk assessment of BRCA2 unclassified variantsKangjian Wu, Shannon R Hinson, Akihiro Ohashi, et al.
Annals of Surgical Oncology|August 3, 2017
Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 GenesJessemae L Welsh, Tanya L Hoskin, Courtney N Day, et al.
Breast Cancer Research and Treatment|May 25, 2011
Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancerKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.
JCO Precision Oncology|July 16, 2025
Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerSiddhartha Yadav, Fergus J Couch, Sam Hillman, et al.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
Molecular Cell|June 24, 2006
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2Bing Xia, Qing Sheng, Koji Nakanishi, et al.
Pageof 57